Cargando…

Nonalcoholic Fatty Liver Disease and Hepatocellular Carcinoma

Hepatocellular carcinoma (HCC) incidence is increasing worldwide in recent years. Most HCC cases develop in the presence of advanced chronic liver disease related to chronic hepatitis C virus (HCV) infection, chronic hepatitis B (HBV) infection, and alcohol abuse. Approximately 15–50% of HCC cases a...

Descripción completa

Detalles Bibliográficos
Autores principales: Kikuchi, Luciana, Oliveira, Cláudia P., Carrilho, Flair J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3971490/
https://www.ncbi.nlm.nih.gov/pubmed/24738043
http://dx.doi.org/10.1155/2014/106247
_version_ 1782309481309274112
author Kikuchi, Luciana
Oliveira, Cláudia P.
Carrilho, Flair J.
author_facet Kikuchi, Luciana
Oliveira, Cláudia P.
Carrilho, Flair J.
author_sort Kikuchi, Luciana
collection PubMed
description Hepatocellular carcinoma (HCC) incidence is increasing worldwide in recent years. Most HCC cases develop in the presence of advanced chronic liver disease related to chronic hepatitis C virus (HCV) infection, chronic hepatitis B (HBV) infection, and alcohol abuse. Approximately 15–50% of HCC cases are classified as idiopathic, suggesting that other risk factors are responsible for its rising incidence. Recent studies suggest that nonalcoholic fatty liver disease (NAFLD) can be associated with these “idiopathic” cases. NAFLD progresses slowly and can develop into liver cirrhosis, liver failure, and HCC. In the last few years, NAFLD has received more attention because of its high prevalence worldwide.
format Online
Article
Text
id pubmed-3971490
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Hindawi Publishing Corporation
record_format MEDLINE/PubMed
spelling pubmed-39714902014-04-15 Nonalcoholic Fatty Liver Disease and Hepatocellular Carcinoma Kikuchi, Luciana Oliveira, Cláudia P. Carrilho, Flair J. Biomed Res Int Review Article Hepatocellular carcinoma (HCC) incidence is increasing worldwide in recent years. Most HCC cases develop in the presence of advanced chronic liver disease related to chronic hepatitis C virus (HCV) infection, chronic hepatitis B (HBV) infection, and alcohol abuse. Approximately 15–50% of HCC cases are classified as idiopathic, suggesting that other risk factors are responsible for its rising incidence. Recent studies suggest that nonalcoholic fatty liver disease (NAFLD) can be associated with these “idiopathic” cases. NAFLD progresses slowly and can develop into liver cirrhosis, liver failure, and HCC. In the last few years, NAFLD has received more attention because of its high prevalence worldwide. Hindawi Publishing Corporation 2014 2014-03-11 /pmc/articles/PMC3971490/ /pubmed/24738043 http://dx.doi.org/10.1155/2014/106247 Text en Copyright © 2014 Luciana Kikuchi et al. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review Article
Kikuchi, Luciana
Oliveira, Cláudia P.
Carrilho, Flair J.
Nonalcoholic Fatty Liver Disease and Hepatocellular Carcinoma
title Nonalcoholic Fatty Liver Disease and Hepatocellular Carcinoma
title_full Nonalcoholic Fatty Liver Disease and Hepatocellular Carcinoma
title_fullStr Nonalcoholic Fatty Liver Disease and Hepatocellular Carcinoma
title_full_unstemmed Nonalcoholic Fatty Liver Disease and Hepatocellular Carcinoma
title_short Nonalcoholic Fatty Liver Disease and Hepatocellular Carcinoma
title_sort nonalcoholic fatty liver disease and hepatocellular carcinoma
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3971490/
https://www.ncbi.nlm.nih.gov/pubmed/24738043
http://dx.doi.org/10.1155/2014/106247
work_keys_str_mv AT kikuchiluciana nonalcoholicfattyliverdiseaseandhepatocellularcarcinoma
AT oliveiraclaudiap nonalcoholicfattyliverdiseaseandhepatocellularcarcinoma
AT carrilhoflairj nonalcoholicfattyliverdiseaseandhepatocellularcarcinoma